Sort
64,565 grants matching “drug discovery”
Membrane-active quinoline and quinazoline antibacterials that target Gram positive pathogens
$782,863Ambrose L. Cheung · Dartmouth College · R01 · FY2020 · AI
Roles of HIV-1 capsid-binding FG-motif containing cellular cofactors in infection
$782,859Mamuka Kvaratskhelia · University Of Colorado Denver · R01 · FY2023 · AI
New antifungals targeting the synthesis of fungal sphingolipids
$782,800Maurizio Del Poeta · State University New York Stony Brook · R01 · FY2021 · AI
Innovative Glycomic/Glycoproteomic Investigation on Alzheimerâs Disease
$782,675Jun Yin · Georgia State University · R56 · FY2018 · AG
The Genetic Basis of Opioid Dependence Vulnerablility in a Rodent Model
$782,581Peter W Kalivas · Medical University Of South Carolina · U01 · FY2022 · DA
Using Omics to Understand the Effects of Drug Abuse on HIV Latent Reservoir
$782,553Eric O Johnson · Research Triangle Institute · R61 · FY2019 · DA
Specification and Function of Tissue Resident and Recruited Macrophages in Cardiac Remodeling and Heart Failure
$782,500Kory J. Lavine · Washington University · R35 · FY2023 · HL
AMPAR ligand discovery for Alzheimer's disease
$782,498Steven H Liang · Emory University · R01 · FY2024 · AG
Poly (ADP-ribose) polymerase ligand discovery for Alzheimer's disease
$782,495Steven H Liang · Emory University · R01 · FY2025 · AG
Translation of GluN2B-selective PET radiopharmaceuticals in Alzheimers patients
$782,495Steven H Liang · Emory University · R01 · FY2023 · AG
Subtype-selective phosphodiesterase PET ligands
$782,492Steven H Liang · Emory University · R01 · FY2023 · AG
Designer Drugs: The Emerging Face of Drug Abuse
$782,384Marilyn A Huestis · National Institute On Drug Abuse · ZIA · FY2015 · DA
Subtype-selective NMDA ligands for Alzheimer's Disease
$782,248Steven H Liang · Emory University · R01 · FY2022 · AG
Leukocyte Gene Expression and Genetic Biomarkers of OA Incidence and Progression
$782,244Steven B Abramson · New York University School Of Medicine · R01 · FY2012 · AR
Integrative multi-omics for discovery of molecular pathways associated with diabetic retinopathy
$782,235Dolly Ann Padovani-Claudio · Vanderbilt University Medical Center · R01 · FY2024 · EY
Precision Phenomics to Personalize Drug Therapy (P3DT)
$782,210Joshua C. Denny · Vanderbilt University Medical Center · P50 · FY2017 · GM
Developing new antifungals against sterolglycosidases
$782,178Maurizio Del Poeta · State University New York Stony Brook · R01 · FY2025 · AI
Discovery of Antivirals Targeting Mpox Virus
$782,142Stefan G Sarafianos · Emory University · R01 · FY2024 · AI
Validation of Lens Beta-Amyloid as a Novel Biomarker for Early Detection of Alzheimer's Disease at the Boston University Alzheimer's Disease Research
$782,114Lee E Goldstein · Boston University Medical Campus · R01 · FY2025 · AG
Small GTPase signaling in dendrites and spines
$782,079Peter Penzes · Northwestern University At Chicago · R56 · FY2020 · MH
Leadership, Planning, and Evaluation
$782,071Gary K Schwartz · Case Western Reserve University · P30 · FY2023 · CA
Leadership, Planning, and Evaluation
$782,071Gary K Schwartz · Case Western Reserve University · P30 · FY2024 · CA
Development and Regulation of Emotion in Primates
$782,066Ned H Kalin · University Of Wisconsin-Madison · R01 · FY2017 · MH
Genetics of Elevated High Density Lipoprotein Cholesterol
$782,029Daniel James Rader · University Of Pennsylvania · R01 · FY2010 · HL
Development and validation of a novel 3D human in vitro model of nonalcoholic steatohepatitis to be used for novel therapeutic screening and research on disease mechanism.
$782,018Alice Chen · Organovo, Inc. · R44 · FY2018 · DK